What are the most common side effects of atorvastatin (Lipitor) in middle-aged to elderly individuals with a history of high cholesterol or cardiovascular disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Side Effects of Atorvastatin

The most common side effects of atorvastatin are nasal congestion, sore throat, runny nose, diarrhea, urinary tract infection, nausea, muscle spasms, throat pain, muscle and joint pain, pain in extremities, upset stomach, musculoskeletal pain, and trouble sleeping. 1

Gastrointestinal Effects

  • Gastrointestinal upset is the most frequently reported adverse effect across clinical trials, including nausea, diarrhea, and upset stomach 1, 2
  • Complex gastrointestinal disturbances occurred in approximately 1.2% of patients in real-world practice 3

Musculoskeletal Effects

  • Muscle-related symptoms including myalgia, muscle spasms, muscle and joint pain, and pain in extremities are common but typically mild 1
  • Myalgia without creatine kinase elevation led to discontinuation in only 0.5% of patients in daily practice 3
  • Atorvastatin is associated with a low incidence of muscular toxicity compared to other statins like simvastatin 4
  • Serious muscle problems (myopathy with marked CK elevation) are rare but can occur, particularly in patients ≥65 years, those taking higher doses, or those with thyroid problems or kidney disease 1

Respiratory Symptoms

  • Upper respiratory symptoms including nasal congestion, sore throat, runny nose, and throat pain are among the most commonly reported side effects 1

Hepatic Effects

  • Liver enzyme elevations occur more frequently with atorvastatin 80 mg/day but do not appear to confer increased risk of clinically important adverse events 4
  • Increased liver transaminases led to discontinuation in only 0.4% of patients in real-world practice 3
  • Liver function should be monitored before starting therapy and if symptoms of liver problems develop 1

Metabolic Effects

  • Blood sugar levels may increase while taking atorvastatin, with approximately 1-5% of patients developing new-onset diabetes over 4-5 years of treatment 5, 1
  • The risk is higher with high-intensity therapy (4.8% vs 3.5% on placebo) compared to moderate-intensity therapy (1.2-1.5% vs 1.2% on placebo) 5
  • The cardiovascular benefits overwhelmingly outweigh diabetes risk, with 5.4 cardiovascular events prevented for every one case of diabetes induced 5

Overall Tolerability Profile

  • Atorvastatin is generally well tolerated across the therapeutic dosage range of 10-80 mg/day 6, 4
  • In real-world practice, only 1.6% of patients discontinued therapy due to drug-related adverse effects 3
  • No cases of rhabdomyolysis were reported in a large observational study of 3,227 patients 3
  • Atorvastatin does not require dosage adjustment in patients with renal dysfunction due to its favorable pharmacokinetic profile 4

Age-Related Considerations

  • In patients ≥65 years, atorvastatin is well tolerated with no dose-dependent increase in adverse events up to 80 mg/day 4
  • Elderly patients have higher chances of muscle problems, particularly if taking higher doses, drinking large amounts of grapefruit juice, or having uncontrolled thyroid problems 1
  • Moderate-intensity statin therapy (atorvastatin 10-20 mg) may be preferable in patients >75 years due to higher risk of adverse events with high-intensity therapy 7

Critical Warnings

  • Patients should immediately report unexplained muscle pain, tenderness, or weakness, especially with fever or unusual fatigue 1
  • Avoid drinking more than 1.2 liters of grapefruit juice daily 1
  • Watch for signs of liver problems including fatigue, nausea, loss of appetite, upper belly pain, dark urine, or yellowing of skin/eyes 1

References

Guideline

Statin-Associated Diabetes Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Atorvastatin: safety and tolerability.

Expert opinion on drug safety, 2010

Guideline

Statin Therapy in Elderly Patients with Coronary Artery Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.